Molecules 2010, 15
4211
products and pure products (~95% by proton NMR) were isolated through crystallization (dichloromethane-hexane).
Compounds obtained from entries 5, 6 and 9–11 (Table 2) were previously reported [13-15]. The remaining
compounds (entries 1–4, 7, 8 and 12, Table 2) have been characterized by IR, NMR and mass spectral data. Our
products gave satisfactory spectral and mp data matching with the reported values. We also carried out a reaction of
benzil and ortho-phenylenediamine in absence of iodine (entry 13) following the published procedure [14]. However,
no reaction took place at 50 °C without catalyst, even after 5 minutes of microwave irradiation; thus suggesting a
lowering of the activation energy in the presence of the catalyst that also reduces the possibility of product loss due to
partial charring.
4. Conclusions
In conclusion, the iodine-catalyzed microwave-induced quinoxaline synthesis as described herein is
very simple, environmentally friendly and extremely rapid and affords high (almost quantitative)
yields. Our method is versatile since aliphatic and aromatic amino compounds can be used in this
reaction and these substrates all produce quinoxalines with remarkable success.
Acknowledgements
We gratefully acknowledge the funding support from National Cancer Institute (NIH/NCI-P20,
Grant# 5P20CA138022-02).
References
1.
Hazeldine, S.T.; Polin, L.; Kushner, J.; Paluch, J.; White, K.; Edelstein, M.; Palomino, E.; Corbett,
T.H.; Horwitz, J.P. Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor
Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469). J. Med. Ch em.
2001, 44, 1758–1776.
2.
3.
4.
Seitz, L.E.; Suling, W.J.; Reynolds, R.C. Synthesis and Antimycobacterial Activity of Pyrazine
and Quinoxaline Derivatives. J. Med. Chem. 2002, 45, 5604–5606.
Badran, M.M.; Botros, S.; El-Gendy, A.A.; Abdou, N.A.; El-Assi, H.; Salem, A. Part I: novel
quinoxaline derivatives of biological interest. Bull. Pharm. Sci. 2001, 24, 135–144.
Bailly, C.; Echepare, S.; Gago, F.; Waring, M.J. Recognition elements that determine affinity and
sequence-specific binding to DNA of 2QN, a biosynthetic bis-quinoline analogue of echinomycin.
Anti Canc. Drug Des. 1999, 14, 291–303.
5
.
.
Sato, K.; Shiratori, O.; Katagiri, K. Mode of action of quinoxaline antibiotics. Interaction of
quinomycin A with deoxyribonucleic acid. J. Antibiot. 1967, 20, 270–276.
6
Becker, F.F.; Banik, B.K. Polycyclic aromatic compounds as anticancer agents: synthesis and
biological evaluation of some chrysene derivatives. Bioorg. Med. Chem. Lett.
877–2880.
1998, 8,
2
7.
Becker, F.F.; Mukhopadhyay, C.; Hackfeld, L.; Banik, I.; Banik, B.K. Polycyclic aromatic
compounds as anticancer agents: synthesis and biological evaluation of dibenzofluorene
derivatives. Bioorg. Med. Chem. 2000, 8, 2693–2699.